Ethnomedicinal and phytopharmacological potential of Crataegus oxyacantha Linn. - A review

Asian Pacific Journal of Tropical Biomedicine

Volumn 2, Issue 2 SUPPL., 2012, Pages

  Kashyap, C P ^a   Arya, Vikrant ^a   Thakur, Narender ^b  

^a College of Ayurvedic Pharmaceutical Sciences ^*  (India)

^b Manav Bharti University   (India)

Author keywords

Cardioprotective; Crataegus oxyacantha; Phenolics; Procyanidins

Indexed keywords

ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; CRATAEGISAN; CRATAEGUS OXYACANTHA EXTRACT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE; FLAVONOID; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN; MANGIFERA INDICA EXTRACT; MILRINONE; OUABAIN; PLACEBO; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PROCYANIDIN; PROPRANOLOL; RANITIDINE; TINCTURE OF CRATAEGUS; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN;

ACUTE STRESS ULCER; ANTIARRHYTHMIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANXIETY; ANXIETY DISORDER; BARK; BERRY; BRADYCARDIA; CRATAEGUS; CRATAEGUS OXYACANTHA; DEPRESSION; DIAPHRAGM PARALYSIS; DIZZINESS; DRUG ACTIVITY; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG POTENTIATION; FLOWER; GASTROINTESTINAL SYMPTOM; GENERALIZED ANXIETY DISORDER; GEOGRAPHIC DISTRIBUTION; HEART ARREST; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PALPITATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; IMMUNOMODULATION; LOW DRUG DOSE; MIGRAINE; NAUSEA; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PLANT STRUCTURES; PLANT TAXONOMY; PRIORITY JOURNAL; REPERFUSION INJURY; RESPIRATION DEPRESSION; REVIEW; SOLVENT EXTRACTION; STRESS ULCER; TRADITIONAL MEDICINE; UNSPECIFIED SIDE EFFECT; VERTIGO;

ANIMALIA; CRATAEGUS; CRATAEGUS MONOGYNA; ROSACEAE;

EID: 84865966745     PISSN: 22211691     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2221-1691(12)60383-9     Document Type: Article

References (51)

1. Horne S, Montgomery M Hawthorn. Natures Fields 2005, 21(12):1-8.
2. Lasseigne FT, Blazich FA Crataegus L 2009, North Carolina State University, Department of Horticultural Science.
3. Donmez AA The Genus Crataegus L. (Rosaceae) with Special Reference to Hybridisation and Biodiversity in Turkey. Turk J Bot 2004, 28:29-37.
4. Peschel W, Bohr C, Plescher A Variability of total flavonoids in Crataegus-factor evaluation for the monitored production of industrial starting material. Fitoterapia 2008, 79:6-20.
5. Krzeminski T, Chatterjee SS Ischemia and early reperfusion-induced arrhythmias: beneficial effects of an extract of Crataegus oxyacantha L. Pharmacy and Pharmacological Letters 1993, 3:45-48.
6. Potter D Phylogeny and classification of Rosaceae. Plant Systematics and Evolution 2007, 266(1-2):5-43.
7. Rasmussen P HawthornCrataegus monogyna (common hawthorn) or Crataegus laevigata (midland hawthorn;Crataegus oxyacantha); also known as haw, thornapple, maythorn, whitethorn. J Prim Health Care 2011, 3(1):63-64.
8. WHO monographs on medicinal plants newly independent states 2003 Pp. 91-93.
9. Huang Y, Chen ZY, Ho WKK. Herbal and Traditional Medicine, Biomolecular and Clinical Aspects. 2, China: 2004.
10. Verma SK, Jain V, Verma D, Khamesra R Crataegus oxyacantha-A Cardioprotective Herb. J Herbal Med Toxicology 2007, 1:65-71.
11. Scala BP Homeopathic treatment of two patients with coronary artery disease: case-report. Int J High Dilution Res 2009, 8(27):45-49.
12. Miller AL Botanical influences on cardiovascular disease. Altern Med Rev 1998, 3(6):422-431.
13. Chen JD, Wu YZ, Tao ZL, Chen ZM, Liu XP Hawthorn (shan zha) drink and its lowering effect on blood lipid levels in humans and rats. World Rev Nutr Diet 1995, 77:147-154.
14. Ju LY Crataegus oxyacantha (aubepine) in the use as herb medicine in France. Zhongguo Zhong Yao Za Zhi 2005, 30(8):634-640.
15. (Accessed on 02-02-2011). http://www.toddcaldecott.com.
16. (Accessed on 02-02-2011). http://www.stevenfoster.com.
17. Rigelsky JM, Sweet BV Hawthorn: Pharmacology and therapeutic uses. Am J Health Syst Pharm 2002, 59(5):417-422.
18. Bersin T, Muller A, Schwarz H Ingredients of Crataegus oxyacantha L. III. Heptahydroxyflavan glycoside. Arzneimittelforschung 1955, 5(8):490-491.
19. Rewerski W, Lewak S Some pharmacological properties of flavan polymers isolated from hawthorn (Crataegus oxyacantha). Arzneimittelforschung 1967, 17(4):490-491.
20. Saija A, Germano MP, Marzullo D, Imperatore C, Campo S, De Pasquale R The determination of catecholamines in Crataegus oxyacantha L. Flowers and leaves by high pressure liquid chromatography-electrochemical detection. Phytochem Analysis 1992, 3:254-257.
21. Sokol-Letowska A, Oszmianski J, Wojdylo A Antioxidant activity of phenolic compounds of Hawthorn, pine, skullcap. Food Chem 2007, 103(3):853-859.
22. Bilia AR, Eterno F, Bergonzi MC, Mazzi G, Vincieri FF Evaluation of the content and stability of the constituents of mother tinctures and tinctures: the case of Crataegus oxyacantha L. and Hieracium pilosella L. J Pharm Biomed Anal 2007, 44(1):77-78.
23. Massoni G On the use of hawthorn extract (Crataegus) in the treatment of certain ischemic myocardial diseases in old age. G Gerontol 1968, 16(9):979-984.
24. Tadic VM, Dobric S, Markovic G, Dordevic SM, Arsic IA, Menkovic NR, Stevic T Anti inflammatory, gastroprotective, free-radical-scavenging, and antimicrobial activities of hawthorn berries ethanol extract. J Agr Food Chem 2008, 56:7700-7709.
25. Zick SM, Gillespie B, Aaronson KD The effect of Crataegus oxycantha special extract WS 1442 on clinical progression in patients with mild to moderate symptoms of heart failure. Eur J Heart Failure 2008, 10(6):587-593.
26. Zhang Z, Chang Q, Zhu M, Huang Y, Chen Z Characterization of antioxidants present in Hawthorn fruits. J Nutr Biochem 2001, 12(3):183-186.
27. Abdul-Ghani AS Hypotensive effect of Crataegus oxyacantha. Int J Crude Drug Res 1987, 25:216-220.
28. Shanthi S, Parasakthy K, Deepalakshmi PD Hypolipidaemic activity of tincture of Crataegus in rats. Indian J Biochem Biophys 1994, 31(2):143-146.
29. Silva AP, Silva ML, Filomena M Antioxidants in Medicinal Plant Extracts. A Research Study of the Antioxidant Capacity of Crataegus, Hamamelis and Hydrastis. Phytother Res 2000, 14:612-616.
30. Chopdat IF The efficacy of Crataegus oxyacantha on refractory hypertension in males 2000, 51-82. Faculity of Health Sciences, Johannesburg.
31. Lacaille-Dubois, Franck U Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine 2001, 8(1):47-52.
32. Degenring FH, Suter A, Weber M, Saller RA Randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan®) in the treatment of patients with congestive heart failure NYHA II. Phytomedicine 2003, 10:363-369.
33. Hanus M, Lafron J, Mathieu M Double-blind, randomised, placebo-controlled study to evaluate the efficacy and safety of a fixed combination containing two plant extracts (Crataegus oxyacantha and Eschscholtzia californica) and magnesium in mild-to-moderate anxiety disorders. Curr Med Res Opin 2004, 20(1):63-71.
34. Jayalakshmi R, Thirupurasundari CJ, Niranjali Devaraj S Pretreatment with alcoholic extract of Crataegus oxycantha (AEC) activates mitochondrial protection during isoproterenol - induced myocardial infarction in rats. Mol Cell Biochem 2006, 292:59-67.
35. Long SR, Carey RA, Crofoot KM, Proteau PJ, Filtz TM Effect of hawthorn (Crataegus oxycantha) crude extract and chromatographic fractions on multiple activities in a cultured cardiomyocyte assay. Phytomedicine 2006, 13:643-650.
36. Akila M, Devaraj H Synergistic effect of tincture of Crataegus and Mangifera indica L. extract on hyperlipidemic and antioxidant status in atherogenic rats. Vasc Pharmacol 2008, 49(4-6):173-177.
37. Jayachandran K, Mahmood K, Karuppaiyah S, Niranjali DS, Periannan K Crataegus oxycantha Extract Attenuates Apoptotic Incidence in Myocardial Ischemia-Reperfusion Injury by Regulating Akt and Hif-1 Signaling Pathways. J Cardiovasc Pharmacol 2010, 56(5):526-531.
38. Elango C, Devaraj SN Immunomodulatory effect of Hawthorn extract in an experimental stroke model. J Neuroinflamm 2010, 7:97.
39. Kanyonga MP, Faouzi MYA, Zellou A, Essassi M, Cherrah Y Effect of methanolic extract of Crataegus oxyacantha on blood haemostasis in rats. J Chem Pharm Res 2011, 3(3):713-717.
40. Kim SH, Kang KW, Kim KW Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta. Life Sci 2000, 67(2):121-131.
41. Weikl A, Assmus KD, Neukum-Schmidt A Crataegus special extract WS 1442: Assessment of objective effectiveness in patients with heart failure. Fortschr Med 1996, 114:291-296.
42. Schmidt U Efficacy of the Hawthorn (Crataegus) preparation L1 132 in 78 patients with chronic congestive heart failure defined as NHYA. Phytomedicine 1994, 1:17-24.
43. Ammon HPT, Handel M Crataegus toxicology and pharmacology, Part III. Planta Med 1981, 43:313-322.
44. Ammon HPT, Handel M Crataegus toxicology and pharmacology. Planta Med 1981, 43:105-120.
45. Daniele C, Mazzanti G, Pitter MH, Ernst E Adverse-event profile of Crataegus spp, a systematic review. Drug Saf 2006, 29:523-535.
46. McGuffin M Botanical safety hand book. Phytomedicine 1997, 42-44.
47. Pittler MH, Schmidt K, Ernst E Hawthorn Extract for Treating Chronic Heart Failure: Meta-analysis of Randomized Trials. Am J Med 2003, 114:665-671.
48. Al Makdessi, Sweidan H, Mullner S Myocardial protection by pretreatment with Crataegus oxyacantha: an assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langendorff heart. Arzneimittel Forschung 1996, 46(1):25-27.
49. Al Makdessi S, Sweidan H, Dietz K Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no flow ischemia in the rat heart. Basic Res Cardiol 1999, 94(2):71-77.
50. Tabach R, Mattei R Araujo Carlini ELD Pharmacological evaluation of a phytotherapeutic product - CPV (dry extract of Crataegus oxyacantha L., Passiflora incarnata L. and Valeriana officinalis L.) in laboratory animals. Brazilian J Pharmacognosy 2009, 19:255-260.
51. Ernst E Herbal remedies for depression and anxiety. Adv Psychiatr Treat 2009, 15:49-56.